Form 8-K - Current report:
SEC Accession No. 0001171843-22-001488
Filing Date
2022-03-01
Accepted
2022-03-01 13:54:27
Documents
16
Period of Report
2022-02-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_030122.htm   iXBRL 8-K 16239
2 EXHIBIT 99.1 exh_991.htm EX-99.1 11708
3 EXHIBIT 99.2 exh_992.htm EX-99.2 10584
4 exh992_01.jpg GRAPHIC 114179
  Complete submission text file 0001171843-22-001488.txt   407124

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3069
6 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25640
7 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
8 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
10 EXTRACTED XBRL INSTANCE DOCUMENT f8k_030122_htm.xml XML 3119
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 22696533
SIC: 2834 Pharmaceutical Preparations